Andy Stergachis

Adjunct Professor, Epidemiology
Professor, Pharmacy
Professor, Global Health
Adjunct Professor, Health Metrics Sciences
Associate Dean, School of Pharmacy



PhD Pharmacy, University of Minnesota, 1979
MS Pharmacy, University of Minnesota, 1976
BPharm Pharmacy, Washington State University, 1975



Office H-362B, Health Sciences Building
Box 357631

Research Interests

Dr. Stergachis' research focus is pharmacoepidemiology, global drugs and vaccine safety, pharmaceutical outcomes research, and public health systems research. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries. He is one of very few pharmacists ever elected to the National Academy of Medicine. His research has been supported, in part, by the Bill and Melinda Gates Foundation, USAID, the Barr Foundation, the Partnership for Quality Medical Donations, and USP. He is a Fellow of the International Society for Pharmacoepidemiology, Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, Chair of the Low-dose Primaquine Safety Study Group for the WorldWide Antimalarial Resistance Network and member of the Access and Product Management Advisory Committee for Medicines for Malaria Venture. He has conducted pharmacovigilance trainings and related pharmaceutical systems strengthening activities in numerous low- and middle-income countries (e.g., Namibia, Vietnam, Rwanda, Ethiopia, Zimbabwe, China, India, Kenya, Bangladesh, Eritrea, Philippines, Uganda, and Ukraine). Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.

Recent Publications (PubMed)

Development and evaluation of a continuous quality improvement programme for antimicrobial stewardship in six hospitals in Uganda.
(2023 Jun)
BMJ Open Qual 12(2):
Kiggundu R, Waswa JP, Nakambale HN, Kakooza F, Kassuja H, Murungi M, Akello H, Morries S, Joshi MP, Stergachis A, Konduri N

Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
(2023 Jun)
J Int AIDS Soc 26(6): e26131
Ortblad KF, Mogere P, Omollo V, Kuo AP, Asewe M, Gakuo S, Roche S, Mugambi M, Mugambi ML, Stergachis A, Odoyo J, Bukusi EA, Ngure K, Baeten JM

Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol.
(2023 May 8)
BMJ Open 13(5): e070543
AbuShweimeh R, Knudson S, Chaabane S, Pal SN, Skidmore B, Stergachis A, Bhat N

Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis.
(2023 Jun 7)
Vaccine 41(25): 3688-3700
Ciapponi A, Berrueta M, P K Parker E, Bardach A, Mazzoni A, Anderson SA, Argento FJ, Ballivian J, Bok K, Comandé D, Goucher E, Kampmann B, Munoz FM, Rodriguez Cairoli F, Santa María V, Stergachis AS, Voss G, Xiong X, Zamora N, Zaraa S, Buekens PM

Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.
(2023 Apr 3)
BMJ Open 13(4): e069195
Chen Y, Saldarriaga EM, Montano MA, Ngure K, Thuo N, Kiptinness C, Rafferty M, Terris-Prestholt F, Stergachis A, Mugambi ML, Ortblad KF, Sharma M

Show complete publication list